Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report
about
Substandard drugs: a potential crisis for public health.Assessing the impact of substandard copy medicines in developing countries: the experience with imatinib copies.Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer.Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study.Clinical efficacy of generic imatinib
P2860
Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Failure of a non-authorized co ...... yeloid leukemia: a case report
@en
type
label
Failure of a non-authorized co ...... yeloid leukemia: a case report
@en
prefLabel
Failure of a non-authorized co ...... yeloid leukemia: a case report
@en
P2860
P356
P1476
Failure of a non-authorized co ...... yeloid leukemia: a case report
@en
P2093
Hadi Alphonse Goubran
P2860
P2888
P356
10.1186/1752-1947-3-7112
P407
P577
2009-04-29T00:00:00Z
P5875
P6179
1036809996